Transcription of Clinical Trial Protocol
{{id}} {{{paragraph}}}
Example: bankruptcy
Clinical Trial Protocol
Clinical Trial ProtocolDoc. No.: c01765254-09 EudraCT No.:BI Trial No. InvestigationalProduct:BIBF 1120 (nintedanib)Title:An open-labelextension trialof the long term safety of oral BIBF1120 in patients with Idiopathic Pulmonary Fibrosis(IPF) Clinical Phase:IIIT rial Clinical Monitor:Phone : Fax: Co-ordinating Investigator:Phone: Fax: Status:Final Protocol (Revised Protocol (based on Global Amendment 3))Version and Date: :28 Mar2017 Page 1 of 66 Proprietary confidential information. 2017 boehringer Ingelheim International GmbH or one or more of its affiliated companies.
Boehringer Ingelheim Name of finished product: Not applicable Name of active ingredient: BIBF 1120 (nintedanib) Protocol date: Trial number: Revision date: 27 Jan 2012 1199.33 28 Mar 2017 Title of trial: An open-label extension trial of the long term safety oforal BIBF 1120 in patients with Idiopathic Pulmonary Fibrosis (IPF) Co-ordinating ...
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: